INTERNATIONAL PATENT: DANA-FARBER CANCER INSTITUTE, INC. FILES APPLICATION FOR "SELECTIVE INHIBITION OF MDM2-AMPLIFIED CANCERS USING TARGETED PROTEIN DEGRADERS"

GENEVA, April 17 -- DANA-FARBER CANCER INSTITUTE, INC. (450 Brookline AvenueBoston, MA 02215-5450) filed a patent application (PCT/US2024/049550) for "SELECTIVE INHIBITION OF MDM2-AMPLIFIED CANCERS USING TARGETED PROTEIN DEGRADERS" on Oct 02, 2024. With publication no. WO/2025/076057, the details related to the patent application was published on Apr 10, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): QI, Jun (c/o Dana-Farber Cancer Institute, Inc.450 Brookline AvenueBoston, MA 02215-5450), BEVILL, Samantha (c/o Dana-Farber Cancer Institute, Inc.450 Brookline AvenueBoston, MA 02215-5450), BE...